Dion Dong

S

Seed Investor

Streamlane

Jan 2024 - Current (2 years 6 months)

L

Seed Investor

Latii

Jan 2024 - Current (2 years 6 months)

Seed Investor

Creatify AI

Jan 2023 - Current (3 years 6 months)

F

Pre-seed Investor

First Bite

Jan 2023 - Current (3 years 6 months)

L

Principal

Leadout Capital

Jan 2022 - Current (4 years 6 months)

Leadout is an early-stage fund with a focus on founder-market fit. Companies we've backed include: Pavilion, Expo, AtoB, R-Zero, Series Financial, Near Space Labs, and more. Some deals I've sourced and/or worked on: - Stellation (pre-seed, sourced) - Expo (series A) - Liferaft (seed extension) - Creatify AI (pre-seed, sourced) - First Bite (pre-seed, sourced) - Streamlane (pre-seed, sourced) - Latii (seed, sourced) - Stealth Vertical AI (seed, sourced) - Stealth Vertical AI (pre-seed, sourced)

S

Pre-seed Investor

Stellation Care

Jan 2022 - Current (4 years 6 months)

Product Manager

Laika

Jan 2021 - Dec 2022 (2 years)

Working on automating compliance. Product lead for access control, cloud monitoring, vendor management, and pentest

Developer Platforms & Ecosystem

Rippling

Jan 2020 - Dec 2021 (2 years)

Rippling App Store, platform growth, developer ecosystem, apps & identity, integrations

Angel

Personal

Jan 2019 - Current (7 years 6 months)

belvo.com (pre-seed) vellum.ai (seed) deeptune.com (seed) 1stcollab.com (pre-seed) paraform.com (seed) kabcash.com (advisor) joinprospect.com (seed) lemi.bot (seed) scoutcities.com (pre-seed) ego.live (pre-seed) ... and a few more unannounced

International Expansion

Udemy

Jan 2018 - Dec 2018 (1 year)

Helped with Udemy's China expansion efforts

Product

MasterClass

Jan 2018 - Dec 2018 (1 year)

Search & Discovery

O

Founding Investor

Olive Capital

Jan 2018 - Dec 2020 (3 years)

Olive Capital invests in trailblazing founders working in synthetic biology, software, and emergent platforms at the seed stage. Deals worked on: - Akasa Health (revenue cycle management for hospitals) - Orchid Bio (polygenic + embryo screening) - Rewind (T2 diabetes reversal) - Ender (operating system for property management)

Z

Investment Team

ZhenFund 真格基金

Jan 2018 - Dec 2019 (2 years)

Early-stage VC with >$2B in capital raised; concurrently working at Olive Capital, which spun out of ZhenFund. ZF's US portfolio includes Substack, Nuro, Apollo, Tagomi, Bolt Payments, Synthego, Osaro, Spring Discovery, etc.

M

Strategy & Partnerships

Mobike 摩拜单车

Jan 2017 - Dec 2018 (2 years)

Helped with Mobike's US expansion efforts, 3rd hire on the US team. Mobike was acquired by Meituan Dianping for $2.7B in 2018.

About

Detail

Timeline

Résumé